Today’s briefing moves from American farm fields to Buckingham Palace to the machinery of online political fundraising. At stake in each: how power is protected — through federal authority, royal tradition, or election law — and who gets to challenge it.
Trump Invokes Defense Production Act for Farm Chemicals
President Donald Trump on Wednesday signed an executive order invoking the Defense Production Act to expand domestic production of phosphorus and glyphosate, the active ingredient in Roundup.
The White House framed both chemicals as essential to crop yields and national food security, arguing that fertilizer and herbicide supply chains are strategic assets. By boosting domestic production, officials say, the United States can reduce reliance on foreign suppliers and stabilize agricultural output.
But the order also carries significant legal implications. It reportedly provides liability protections for manufacturers that comply with federal labeling standards — a major development for Bayer, which has faced more than 100,000 lawsuits alleging its glyphosate-based products caused non-Hodgkin lymphoma.
The controversy dates back to 2015, when the International Agency for Research on Cancer classified glyphosate as “probably carcinogenic to humans.” Regulatory bodies such as the Environmental Protection Agency and the European Food Safety Authority later insisted glyphosate is not likely carcinogenic at typical exposure levels, though health advocates have raised questions about how that conclusion was reached.
The U.S. Supreme Court has agreed to hear a case that could determine whether federal pesticide law preempts state-level failure-to-warn lawsuits. The Trump administration has urged the Court to side with manufacturers, arguing that compliance with EPA labeling decisions should shield companies from additional state claims.
The executive order has created tension within parts of the “Make America Healthy Again” coalition. Allies of Robert F. Kennedy Jr. and activist groups have long pushed for tighter pesticide controls, arguing that expanded production and federal preemption weaken public health protections.
Supporters counter that glyphosate remains foundational to modern agriculture — and that restricting it without viable substitutes would raise costs and strain the food system.
At its core, the debate pits agricultural stability and regulatory uniformity against precaution and skepticism of corporate influence.
Prince Andrew Arrested in U.K. Investigation
Across the Atlantic, Andrew Mountbatten-Windsor — formerly known as Prince Andrew, Duke of York — was arrested early Thursday on suspicion of misconduct in public office, according to Thames Valley Police.
The arrest took place at his home on the Sandringham estate in Norfolk on his 66th birthday, marking an unprecedented moment in modern British royal history.
The investigation follows the U.S. Department of Justice’s recent release of heavily redacted Epstein-related files. Authorities are examining allegations that during his tenure as U.K. trade envoy, Andrew may have forwarded confidential government trade reports to Jeffrey Epstein.
Police confirmed searches at properties in Norfolk and Berkshire. Under U.K. law, arrest on suspicion does not mean charges have been filed.
King Charles III, in a statement issued through Buckingham Palace, expressed “deep concern” and pledged cooperation with authorities, emphasizing that “the law must take its course.”
Andrew has faced years of scrutiny over his association with Epstein and settled a U.S. civil lawsuit in 2022 without admitting wrongdoing. He was stripped of royal titles and public duties last year following renewed fallout from document disclosures.
Now, for the first time in modern memory, a senior royal sits in police custody.
Judicial Watch Targets ActBlue in New Lawsuit
Back in Washington, Judicial Watch has filed a Freedom of Information Act lawsuit against the Federal Election Commission seeking records related to alleged fraudulent donor activity involving ActBlue.
ActBlue is the primary online fundraising platform for Democratic candidates and progressive causes, processing billions in small-dollar donations.
Judicial Watch argues that ActBlue may have failed to adequately prevent “straw donor” schemes — where contributions are made in another person’s name — and potentially foreign-sourced donations. The group says it filed suit after the FEC did not respond to a September 2025 FOIA request seeking audits, investigative records, and communications related to ActBlue’s donor verification processes.
The lawsuit references an April 2025 congressional staff report alleging that internal ActBlue materials instructed fraud-prevention staff to “look for reasons to accept contributions” rather than default to flagging suspicious activity.
ActBlue has previously denied wrongdoing and maintains that it complies with federal election laws. The lawsuit does not itself allege criminal findings but seeks documents that could shed light on what regulators knew — and when.
As election integrity debates intensify nationwide, the fight over fundraising transparency is moving into the courts.
READ NEXT: FEC Sued For Hidden Records On ActBlue Donor Fraud Allegations
